Literature DB >> 27407640

The Challenge of Enterocutaneous Fistulae.

Rajan Chaudhry1.   

Abstract

During a period of six years, 17 cases of enterocutaneous fistulae arising from the small intestine were managed. Majority of the fistulae, (76%) resulted from surgical complications. There were 6 females and 11 male patients. The mean age of the patients was 40 years. In 9/17 patients (52%) the fistulae arose from the proximal small gut (duodenum and jejunum) and in the remaining 48% from the ileum. Octreotide was used in 11/17 patients (64%). Enteral nutrition was used in 9/17 patients (52%) while re-feed from the proximal gut fistulae was used in 4/9 patients (44%) to maintain the nutrition of the patients. Only one fistula (6%) closed spontaneously. There were 2 deaths (12%) in this study. 14/17 patients (82%) required surgical intervention at some stage for successful closure of intestinal fistula. Aggressive surgical treatment with judicious use of octreotide, nutritional support, stoma care and control of sepsis significantly improves the outcome of small intestinal fistulae.

Entities:  

Keywords:  Enterocutaneous; Fistula; Nutrition; Octreotide

Year:  2011        PMID: 27407640      PMCID: PMC4923209          DOI: 10.1016/S0377-1237(04)80053-4

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  14 in total

1.  Estimating mortality risk in preoperative patients using immunologic, nutritional, and acute-phase response variables.

Authors:  N V Christou; J Tellado-Rodriguez; L Chartrand; B Giannas; B Kapadia; J Meakins; H Rode; J Gordon
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

Review 2.  Somatostatin (second of two parts).

Authors:  S Reichlin
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

3.  [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition].

Authors:  J C Hernández-Aranda; B Gallo-Chico; L A Flores-Ramírez; R Avalos-Huante; F J Magos-Vázquez; E J Ramírez-Barba
Journal:  Nutr Hosp       Date:  1996 Jul-Aug       Impact factor: 1.057

Review 4.  Nutritional consequences of reoperative surgery in recurrent malignancy.

Authors:  F D Ottery
Journal:  Semin Oncol       Date:  1993-10       Impact factor: 4.929

5.  The pathophysiology of enterocutaneous fistulas.

Authors:  J E Fischer
Journal:  World J Surg       Date:  1983-07       Impact factor: 3.352

6.  Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog.

Authors:  S Kocak; C Bumin; K Karayalcin; I Alacayir; D Aribal
Journal:  Dig Dis       Date:  1994 Jan-Feb       Impact factor: 2.404

7.  Treatment of gastrointestinal fistulas with Sandostatin.

Authors:  A Sitges-Serra; X Guirao; J A Pereira; P Nubiola
Journal:  Digestion       Date:  1993       Impact factor: 3.216

Review 8.  Reoperative versus conservative management for gastrointestinal fistulas.

Authors:  J Rubelowsky; G W Machiedo
Journal:  Surg Clin North Am       Date:  1991-02       Impact factor: 2.741

9.  [Value of octreotide in the treatment of postoperative enterocutaneous fistula].

Authors:  J C Sleth; Y Andraos; F Borie; R Dumay; P Legroux
Journal:  Ann Fr Anesth Reanim       Date:  1994

10.  Octreotide for treatment of postoperative alimentary tract fistulas.

Authors:  H Paran; D Neufeld; O Kaplan; J Klausner; U Freund
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

View more
  2 in total

1.  Nutritional Management in Enterocutaneous Fistula. What is the evidence?

Authors:  Manal Badrasawi; Suzana Shahar; Ismail Sagap
Journal:  Malays J Med Sci       Date:  2015 Jul-Aug

Review 2.  Treatment of enterocutaneous fistula: a systematic review and meta-analysis.

Authors:  R Gefen; Z Garoufalia; P Zhou; K Watson; S H Emile; S D Wexner
Journal:  Tech Coloproctol       Date:  2022-08-01       Impact factor: 3.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.